Intravenous (IV) Solutions Market Size To Reach USD 25.10 Billion By 2033, Growing At A CAGR Of 8.24% - SNS Insider

(MENAFN- GlobeNewsWire - Nasdaq) Global Intravenous (IV) Solutions Market growth is driven by rising hospitalization rates, increasing prevalence of chronic diseases, expanding surgical volumes, and growing demand for parenteral nutrition and fluid management.

Austin, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Intravenous (IV) Solutions Market Size & Growth Analysis:

According to SNS Insider, the Intravenous (IV) Solutions Market size was valued at USD 13.35 billion in 2025 and is expected to reach USD 25.10 billion by 2033, growing at a CAGR of 8.24% over the forecast period of 2026–2033.

The increasing use of IV solutions across hospitals, ambulatory surgical centers, and emergency care settings is significantly contributing to market expansion. IV solutions play a critical role in hydration therapy, electrolyte balance, drug delivery, blood volume restoration, and nutritional support, making them essential across a wide range of acute and chronic care applications. Rising surgical procedures, trauma cases, oncology treatments, and intensive care admissions continue to support sustained demand globally.

Get a Sample Report of Intravenous (IV) Solutions Market:

U.S. Intravenous (IV) Solutions Market Insights:

The U.S. Intravenous (IV) Solutions Market size was valued at USD 3.91 billion in 2025 and is projected to reach USD 7.20 billion by 2033, expanding at a CAGR of 7.93% during the forecast period of 2026–2033.

Growth in the U.S. market is driven by advanced healthcare infrastructure, high hospital admission rates, increasing use of IV therapies in chronic disease management, and strong demand from emergency and critical care units. Additionally, rising geriatric population, high prevalence of diabetes, cancer, and renal disorders, and widespread adoption of IV-based drug administration are supporting steady market growth across the country.

Major Players Analysis Listed in this Report are:

• Baxter International Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Grifols, S.A.
• ICU Medical, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Ajinomoto Co., Inc.
• Terumo Corporation
• Pfizer Inc.
• Hospira, Inc.
• Daiichi Sankyo Company, Limited
• Hikma Pharmaceuticals PLC
• Cardinal Health, Inc.
• Abbott Laboratories
• Novartis AG
• Medline Industries, Inc.
• Chongqing Huapont Pharm Co., Ltd.
• Shanghai Fuxing Pharmaceutical Co., Ltd.
• Taisho Pharmaceutical Co., Ltd.
• CJ Healthcare Corporation

Intravenous (IV) Solutions Market Report Scope

Report Attributes	Details
Market Size in 2025	USD 13.35 Billion
Market Size by 2033	USD 25.10 Billion
CAGR	CAGR of 8.24% From 2026 to 2033
Base Year	2025
Forecast Period	2026-2033
Historical Data	2022-2024
Regional Analysis/Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Segmentation Analysis:

By Type

In 2025, Total parenteral nutrition led the market with a share of 65.10% due to its extensive use in hospitals, clinics, and home care settings for patients requiring complete nutritional support. Peripheral parenteral nutrition is the fastest-growing segment with a CAGR of 8.90% supported by rising awareness of targeted, short-term nutritional therapies, convenience of peripheral administration, and growing adoption in ambulatory and home healthcare facilities.

By Composition

In 2025, Parenteral lipid emulsion led the market with a share of 32.60% due to its essential role in providing high-calorie nutritional support to critically ill and malnourished patients. Single-dose amino acids is the fastest-growing segment with a CAGR of 9.20% fueled by the rising need for precise, patient-specific amino acid supplementation, ease of administration, and growing adoption in home healthcare and specialty medical facilities.

By Application

In 2025, Nutritional support led the market with a share of 55.60% due to the growing prevalence of chronic diseases, malnutrition, post-surgical recovery needs, and critical care requirements. Fluid and electrolyte balance is the fastest-growing segment with a CAGR of 8.70% supported by increasing cases of dehydration, electrolyte imbalances, and critical care interventions.

By End-Use

In 2025, Hospitals and clinics led the market with a share of 70.20% due to the high demand for IV solutions in critical care, surgical procedures, and chronic disease management. The home care settings is the fastest-growing segment with a CAGR of 9.50% driven by the increasing preference for at-home treatment, rising awareness of home-based healthcare services, and the convenience of administering IV therapy outside traditional medical facilities.

Need Any Customization Research on Intravenous (IV) Solutions Market, Enquire Now:

Key Intravenous (IV) Solutions Market Segments

By Type

• Total parenteral nutrition
• Peripheral parenteral nutrition

By Composition

• Carbohydrates
• Vitamins and minerals
• Single-dose amino acids
• Parenteral lipid emulsion
• Other compositions

By Application

• Nutritional support
• Blood transfusion
• Fluid and electrolyte balance
• Other applications

By End Use

• Hospitals and clinics
• Ambulatory surgery centers
• Home care settings

Regional Insights:

North America dominated the Intravenous (IV) Solutions Market in 2025, with over 40.70% revenue share, driven by advanced healthcare infrastructure, high prevalence of chronic and critical illnesses, and strong government healthcare funding.

The Asia Pacific region is expected to have the fastest-growing CAGR 9.46%, driven by rising healthcare expenditure, expanding hospital and clinic infrastructure, and increasing awareness of advanced IV therapies.

Recent Developments:

• In September 2025, B. Braun received the Nurse Approved Certification for its entire IV Solutions portfolio not made with DEHP or PVC, Plastic Irrigation Containers, and Piperacillin and Tazobactam in DUPLEX® Drug Delivery System, highlighting its commitment to excellence in usability and alignment with nursing practice needs.
• In April 2025, ICU Medical introduced its new category of infusion devices with FDA clearances of Plum Solo and Plum Duo precision IV pumps, offering ±3% accuracy and compatibility with whole blood and blood products.

Purchase Single User PDF of Intravenous (IV) Solutions Market Report (20% Discount):

Exclusive Sections of the Report (The USPs):

• PATIENT-CENTRIC THERAPY UTILIZATION METRICS – helps you understand average IV therapy duration across hospitals, clinics, and home care settings, enabling demand forecasting and care pathway optimization.
• AGE & DISEASE-BASED DEMAND DISTRIBUTION – helps you identify IV solution usage patterns across pediatric, adult, and geriatric populations, as well as key disease areas such as oncology, critical care, post-surgical recovery, and malnutrition.
• HEALTHCARE FACILITY ADOPTION & INFRASTRUCTURE READINESS – helps you assess smart IV pump penetration, annual IV consumption per hospital bed, and staff training levels to gauge operational maturity across facilities.
• PRODUCT INNOVATION & FORMULATION ADOPTION RATES – helps you evaluate the shift toward pre-mixed solutions, advanced amino-acid or lipid-based formulations, and automation in IV compounding for efficiency and safety improvements.
• AUTOMATION & TECHNOLOGY ENABLEMENT INDEX – helps you measure the extent of robotic IV compounding adoption in hospitals, highlighting opportunities for cost reduction and error minimization.
• SUPPLY CHAIN & LOGISTICS PERFORMANCE METRICS – helps you monitor cold-chain compliance, delivery lead times, and inventory turnover rates to identify risks in product availability and distribution efficiency.

Access Complete Report Details of Intravenous (IV) Solutions Market Analysis & Outlook:

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email:...

MENAFN09012026004107003653ID1110578167